Does ALIROCUMAB Cause Muscular weakness? 298 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 298 reports of Muscular weakness have been filed in association with ALIROCUMAB (Praluent). This represents 1.3% of all adverse event reports for ALIROCUMAB.
298
Reports of Muscular weakness with ALIROCUMAB
1.3%
of all ALIROCUMAB reports
3
Deaths
26
Hospitalizations
How Dangerous Is Muscular weakness From ALIROCUMAB?
Of the 298 reports, 3 (1.0%) resulted in death, 26 (8.7%) required hospitalization.
Is Muscular weakness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALIROCUMAB. However, 298 reports have been filed with the FAERS database.
What Other Side Effects Does ALIROCUMAB Cause?
Myalgia (1,571)
Product dose omission (1,354)
Injection site pain (1,220)
Muscle spasms (1,113)
Arthralgia (993)
Fatigue (922)
Pain (892)
Pain in extremity (888)
Product dose omission issue (864)
Injection site bruising (821)
What Other Drugs Cause Muscular weakness?
ADALIMUMAB (3,605)
METHOTREXATE (2,813)
RITUXIMAB (2,621)
ATORVASTATIN (2,494)
PREDNISONE (2,236)
ETANERCEPT (2,207)
DALFAMPRIDINE (1,916)
TOCILIZUMAB (1,790)
FINGOLIMOD (1,769)
SECUKINUMAB (1,747)
Which ALIROCUMAB Alternatives Have Lower Muscular weakness Risk?
ALIROCUMAB vs ALISKIREN
ALIROCUMAB vs ALISKIREN HEMIFUMARATE
ALIROCUMAB vs ALISKIREN\HYDROCHLOROTHIAZIDE
ALIROCUMAB vs ALIZAPRIDE
ALIROCUMAB vs ALLANTOIN